C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2011
10/12/2011	CN102216305A Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
10/12/2011	CN102216304A Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
10/12/2011	CN102216303A Process for the preparation of 2-(primary/secondary amino)hydrocarbyl)- carbamoyl-7-oxo-2,6-diaza-bicyclo[3.2.0.]heptane-6-sulfonic acid derivatives
10/12/2011	CN102216298A Imidazopyridines and imidazopyrimidines as HIV-1 reverse transcriptase inhibitors
10/12/2011	CN102216273A Naphthylacetic acids used as crth2 antagonists or partial agonists
10/12/2011	CN102212066A Condensed-cyclic compound and organic light-emitting device including the same
10/11/2011	US8034959 Methods of treating cancer with an antibody-drug conjugate
10/11/2011	US8034949 Pyrrolidine compound and a process for preparing the same
10/11/2011	US8034941 Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
10/11/2011	US8034927 Macrocyclic dyes having naphthyl moieties
10/11/2011	US8034832 Gyrase inhibitors and uses thereof
10/11/2011	US8034821 Selective serine/threonine kinase inhibitors
10/11/2011	US8034812 Imidazopyridazine derivative having kinase inhibitory activity and pharmaceutical agent thereof
10/11/2011	US8034806 Bicyclic mGluR5 positive allosteric modulators and methods of making and using same
10/11/2011	US8034800 Cross-bridged tetraamine macrocycles complexed with transition metal ions, radioactive metal species, fluorescent tag; as CXCR4 co-receptor antagonist is a dosage form for treatment of HIV; radiopharmaceutical for imaging chemokine receptors; drug screening assays for chemokine receptor binding
10/11/2011	CA2587328C New derivatives of porphyrin including chlorine and/or bacteriochlorins and their applications in photodynamic therapy
10/11/2011	CA2564372C Hiv integrase inhibitors
10/11/2011	CA2552106C Novel indeno[2,1a]indenes and isoindol[2,1-a]indoles
10/11/2011	CA2514191C Compound inhibiting dipeptidyl peptidase iv
10/06/2011	WO2011123751A2 Heterocyclic compounds and their uses
10/06/2011	WO2011123678A2 Substituted benzo-pyrido-triazolo-diazepine compounds
10/06/2011	WO2011123641A1 Solid state forms of sitagliptin salts
10/06/2011	WO2011123536A1 Polycyclic tetracycline compounds
10/06/2011	WO2011123493A1 Substituted pyrrolotriazines as protein kinase inhibitors
10/06/2011	WO2011123372A1 Purine compounds
10/06/2011	WO2011121309A1 Phenyl sulfonyl derivatives and their use as histamine h3 antagonists
10/06/2011	WO2011121223A1 6-(alkyl- or cycloalkyl-triazolopyridazine-sulfanyl) benzothiazole derivatives: preparation, application as medicaments and use as met inhibitors
10/06/2011	WO2011121137A1 Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders
10/06/2011	WO2011121105A1 Macrocyclic integrase inhibitors
10/06/2011	WO2011121096A1 PYRAZOL[1,5-a]PYRIMIDINE DERIVATIVES AS WNT PATHWAY ANTAGONISTS
10/06/2011	WO2011120877A1 Aryl-cyclohexyl-tetraazabenzo[e]azulenes
10/06/2011	WO2011120327A1 Anti-tumor medicament of structure of diarylurea or thiourea kind based on indazole or aza-indazole
10/06/2011	WO2010131035A8 Novel crystalline polymorph of sitagliptin dihydrogen phosphate
10/06/2011	WO2010047956A9 Azolopyrrolone melanin concentrating hormone receptor-1 antagonists
10/06/2011	US20110245499 Process for Resolving Zopiclone
10/06/2011	US20110245498 Solid state forms of sitagliptin salts
10/06/2011	US20110245273 Novel aliphatically substituted pyrazolopyridines, and the use thereof
10/06/2011	US20110245263 2-heteroaryl-pyrrolo[3,4-c]pyrrole derivatives and their use as scd
10/06/2011	US20110245260 Analogs of dehydrophenylahistins and their therapeutic use
10/06/2011	US20110245258 Novel antimicrobials
10/06/2011	US20110245254 Heterocyclic compounds as inhibitors of beta-lactamases
10/06/2011	US20110245252 Pyrrolotriazine kinase inhibitors
10/06/2011	US20110245237 Aryl-cyclohexyl-tetraazabenzo[e]azulenes
10/06/2011	US20110245236 Substituted Benzo-Pyrido-Triazolo-Diazepine Compounds
10/06/2011	US20110245234 Crystalline forms of sodium 4--2-methoxybenzoate
10/06/2011	US20110245229 Dihydropyrazolopyrimidinone derivatives
10/06/2011	US20110245214 Organic compounds
10/06/2011	US20110244481 Coelenterazine analogues and coelenteramide analogues
10/06/2011	US20110243891 Dihydropyrazolopyrimidinone derivative
10/06/2011	US20110240979 Condensed-cyclic compound and organic light-emitting device including the same
10/06/2011	US20110240978 Heterocyclic compound and organic light-emitting device including the same
10/06/2011	US20110240977 Heterocyclic compound and organic light-emitting device including the same
10/06/2011	CA2800507A1 Solid state forms of sitagliptin salts
10/06/2011	CA2799727A1 Polycyclic tetracycline compounds
10/06/2011	CA2795080A1 Purine compounds
10/06/2011	CA2793897A1 Heterocyclic compounds and their uses
10/06/2011	CA2793313A1 Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders
10/06/2011	CA2786657A1 Aryl-cyclohexyl-tetraazabenzo[e]azulenes
10/05/2011	EP2371828A1 Condensed-Cyclic Compound and Organic Light-Emitting Device Including the Same
10/05/2011	EP2371827A1 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
10/05/2011	EP2371219A1 Herbicidal acylhydrazides
10/05/2011	EP2370442A1 3-aminocyclopentanecarboxamides as chemokine receptor modulators
10/05/2011	EP2370441A1 Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists
10/05/2011	EP2370437A1 Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
10/05/2011	EP2370407A1 Carbazole and carboline kinase inhibitors
10/05/2011	EP2294070B1 New phenanthrylphenol linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof
10/05/2011	EP2150553B1 Condensed heterocyclic compounds as inhibitors of protein kinases
10/05/2011	EP1989207B1 Crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
10/05/2011	CN1817883B New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
10/05/2011	CN1553913B Process for the direct preparation of pyrrolo [3,4-c]pyrroles
10/05/2011	CN102209713A 1- (arylsulfonyl) -4- (pi perazin-i -yl) -ih-benz imidazoles as d-hydroxytryptamine- 6 ligands
10/05/2011	CN102206221A Method for extracting chlorophyll from dunaliella by using inorganic alkali
10/05/2011	CN102206220A Preparation method and application of camphor manganese porphyrin
10/05/2011	CN102206219A Method for preparing urotropine by using glyphosate by-product ammonia gas and formaldehyde
10/05/2011	CN102206218A Method for purifying high-purity pemetrexed disodium
10/05/2011	CN102206217A Heterocyclic compounds for treating or preventing diabetes mellitus as dipeptidyl peptidase inhibitor
10/04/2011	US8030343 Phosphodiesterase inhibitor; tumor necrosis factor antagonist; autoimmune diseases; sepsis; malaria ; skin disorders; anticancer agents; antiarthritic agents; Crohn's disease; inflammatory bowel disorders
10/04/2011	US8030342 Dendritic polyamidoamine phthalocyanine derivative
10/04/2011	US8030309 Viral polymerase inhibitors
10/04/2011	US8030306 Azabicyclic heterocycles as cannabinoid receptor modulators
10/04/2011	US8030305 Triazolopyridazines as kinase modulators
10/04/2011	US8030304 Thiazole pyrazolopyrimidines CRF1 receptor antagonists
10/04/2011	US8030300 2-pyrrolidinyloxy-substituted pyridine; Alzheimer's disease, Parkinson's disease, dyskinesias, Tourette's syndrome, schizophrenia, attention deficit disorder, anxiety, pain, depression, obsessive compulsive disorder
10/04/2011	CA2438520C Phthalazinone-piperidino-derivatives as pde4 inhibitors
09/2011
09/29/2011	WO2011119858A1 Analogues for the treatment or prevention of flavivirus infections
09/29/2011	WO2011119457A1 Process for synthesizing 6-bromo-3-(1-methyl-1h-pyrazol-4-yl)-5-(3(r)-piperidinyl)pyrazolo[1,5-a]pyrimidin-7-amine
09/29/2011	WO2011118394A1 Cyclic compound, method for producing cyclic compound, and method for modifying biological molecule
09/29/2011	WO2011117882A1 Pyrrolo[2,l-c][l,4]benzodiazepine-benzothiazole or benzoxazole conjugates linked through piperazine moiety and process for the preparation thereof
09/29/2011	WO2011117668A1 Carbazole linked pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
09/29/2011	WO2011117264A1 N-(imidazopyrimidin-7-yl)-heteroarylamide derivatives and their use as pde10a inhibitors
09/29/2011	WO2011117160A1 Pyrrolopyrazine derivatives and their use as jak and syk inhibitors
09/29/2011	WO2011117145A2 Pyrrolopyrazine kinase inhibitors
09/29/2011	WO2011116865A1 Materials for organic electroluminescence devices
09/29/2011	WO2011116686A1 Sitagliptin intermediate compounds, preparation methods and uses thereof
09/29/2011	WO2011116516A1 Copolymer containing fluorenylporphyrin-benzene, preparation method and use thereof
09/29/2011	WO2011080132A3 Compounds, compositions and methods for controlling biofilms
09/29/2011	WO2011062766A3 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
09/29/2011	WO2011060213A3 Preparation of sitagliptin and salts thereof
09/29/2011	WO2011050068A3 Bivalent diazo bicyclic smac mimetics and the uses thereof
09/29/2011	WO2010151815A3 3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof

1 ... 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 ... 573